Ascentage’s drug shows potential to treat Covid-19 in preclinical study
Olverembatinib showed increased Omicron-NTD-mediated cytokine release suppression compared with ponatinib and baricitinib.
Impact of Chinas Zero COVID lockdowns
Latest in
Impact of Chinas Zero COVID lockdowns
Decoding the Covid-19 connection with diabetes
A growing base of evidence suggests people are significantly more likely to develop diabetes in the months following a Covid-19…
By
FDA declines to grant EUA for antidepressant to treat Covid-19
The data was inadequate to conclude that the drug was effective in preventing disease progression, FDA noted.
Covid-19 patent lawsuits: Will vaccine producers have to pay the bill?
Moderna’s positioning as US contractor for Covid-19 vaccines in a patent lawsuit marks a new development in the infringement disputes.
By
Sound Pharmaceuticals receives NIH grant for Covid-19 therapy development
The grant will support two trials of ebselen in 120 adult subjects with moderate or severe Covid-19.
FDA grants approval for Lilly-Incyte’s Covid-19 treatment
The approval is based on findings from two Phase III clinical trials, ACTT-2 and COV-BARRIER.
COVID-19 health concern declines in April: Poll
The health concern over COVID-19 in April 2022 decreased from March, shows the COVID-19 concern index, which is measured by…
Leverage existing Covid-19 networks to tackle paediatric hepatitis outbreak
The tools established to combat Covid-19 can be proactively leveraged before the hepatitis outbreak becomes any more serious.
By